Back
10x Genomics Quote, Financials, Valuation and Earnings
Sponsored
TXG
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
38
TXG
10x Genomics
Last Price:
14.14
Seasonality Move:
17.75%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here10x Genomics Price Quote
$14.14
-0.78 (-5.23%)
(Updated: November 14, 2024 at 5:55 PM ET)
10x Genomics Key Stats
Sell
38
10x Genomics (TXG)
is a Sell
Day range:
$14.84 - $15.89
52-week range:
$14.02 - $57.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.98
P/B ratio:
2.63%
Volume:
2.1M
Avg. volume:
2.3M
1-year change:
-58.92%
Market cap:
$1.9B
Revenue:
$618.7M
EPS:
$-1.53
How Much Does 10x Genomics Make?
-
How Much Are 10x Genomics's Sales Annually?
TXG Revenues are $618.7M -
How Much Profit Does 10x Genomics's Make A Year?
TXG net income is -$255.1M
Is 10x Genomics Growing As A Company?
-
What Is 10x Genomics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.01% -
What Is 10x Genomics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
10x Genomics Stock Price Performance
-
Did 10x Genomics Stock Go Up Last Month?
10x Genomics share price went down by -8.24% last month -
Did TXG's Share Price Rise Over The Last Year?
TXG share price fell by -58.92% over the past 1 year
What Is 10x Genomics 52-Week High & Low?
-
What Is 10x Genomics’s 52-Week High Share Price?
10x Genomics has traded as high as $57.90 over the past 52 weeks -
What Is 10x Genomics’s 52-Week Low Share Price?
10x Genomics has traded as low as $14.02 over the past 52 weeks
10x Genomics Price To Free Cash Flow
-
Is 10x Genomics Stock Overvalued?
10x Genomics is trading at a price to free cash flow ratio of 75.04 -
Is 10x Genomics Stock Undervalued?
10x Genomics EV to Free Cash Flow ratio is 59.99 -
What Is 10x Genomics’s Price Earnings Growth Ratio?
TXG PEG ratio is 0.00 -
Is 10x Genomics Trading At A Premium To Earnings?
10x Genomics EV to EBIT ratio is 0.00
Is It Risky To Buy 10x Genomics?
-
How Much Debt Does 10x Genomics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 10x Genomics Have?
Cash and short term investments quarterly total is $398.2M -
What Is 10x Genomics’s Book Value Per Share?
Book value per share is 5.97
Is 10x Genomics Cash Flow Positive?
-
What Is TXG Cash Flow From Operations?
Cash flow from operations (TTM) is $39.2M -
What Is 10x Genomics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12M -
What Is 10x Genomics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $32.1M
10x Genomics Return On Invested Capital
-
Is Management Doing A Good Job?
TXG return on invested capital is -24.99% -
What Is 10x Genomics Return On Assets?
ROA measures how assets are converting to revenues and is -19.4% -
What Is TXG Return On Equity?
ROE is a measure of profitability and is -24.99%
10x Genomics Earnings Date & Stock Price
-
What Is 10x Genomics's Stock Price Today?
A single share of TXG can be purchased today for 14.92 -
What Is 10x Genomics’s Stock Symbol?
10x Genomics trades on the nasdaq under the ticker symbol: TXG -
When Is 10x Genomics’s Next Earnings Date?
The next quarterly earnings date for 10x Genomics is scheduled on February 14, 2025 -
When Is TXG's next ex-dividend date?
10x Genomics's next ex-dividend date is May 26, 2020 -
How To Buy 10x Genomics Stock?
You can buy 10x Genomics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
10x Genomics Competitors
-
Who Are 10x Genomics's Competitors?
Below is a list of companies who compete with 10x Genomics or are related in some way:
10x Genomics Dividend Yield
-
What Is TXG Dividend Yield?
10x Genomics’s dividend yield currently is 0% -
What Is 10x Genomics’s Payout Ratio?
10x Genomics’s payout ratio is 0% -
When Did 10x Genomics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is 10x Genomics’s Dividend Per Share?
10x Genomics pays a dividend of $0.00 per share
10x Genomics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 94.13% |
Revenue: | -1.3% | -0.01% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 8 |
Sell Recommendations: | 0 |
Price Target: | 20.29 |
Upside from Last Price: | 35.96% |